Chinese COVID-19 Vaccine Phase 2 Trial Results: Safe and Induces an Immune Response
Phase 2 randomized controlled trial of a recombinant adenovirus type-5-vectored COVID-19 vaccine (Ad5-vectored COVID-19 vaccine) was conducted in China in April 2020 and involved more…